Tweets
RECITAL trial comparing ritux vs cyclo for CTD-ILD. This is a sub-group analysis of larger trial. 1/n
@RheumNow #ACR22 #Plenary
Julian Segan @JulianSegan ( View Tweet )
3 years 8 months ago
GPA is a rare cause of both submandibular gland enlargement and dacryoadenitis. Can look like IgG4RD and Sjogrens.
@RheumNow #ACR22 #Pearls https://t.co/Gw6OF4H2w2
Julian Segan @JulianSegan ( View Tweet )
3 years 8 months ago
Are my patients represented in PsA trials? @RheumNow #ACR22
Abstract #0090; Ignite Talk
☝️Of 25 RCT from 2002-2022, only 13 included patients of non-White race
☝️Hispanic/Latinx ethnicity was reported in 0 studies
☝️Black individuals represented < 1% patients included
Catherine Sims, MD @DrCassySims ( View Tweet )
3 years 8 months ago
Dr. John Stone pronounces GiACTA “GEE-ACTA”. I have been pronouncing it “GIA-ACTA” and will now correct myself #vasculitis #ACR22
Catherine Sims, MD @DrCassySims ( View Tweet )
3 years 8 months ago
#ACR22 Year in Review. Dr Langford summarised significant progress attained in 2022 in combating #COVID and protect our immunosuppressed patients @RheumNow https://t.co/lZSDRj3bkm
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
3 years 8 months ago
Key points in managing MDA5+ DM
1. Monitor lungs - HRCT/PFTs
2. Test muscle endurance (ref: IMACS site) not just strength
3. Close observation
4. MTX/MMF initial treatments
5. Repeat muscle biopsy if diagnosis unclear
Meet the Expert Lundberg I, IMM session @RheumNow #ACR22 https://t.co/ZVFsYgDBx2
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 8 months ago
Key points in managing MDA5+ DM
1. Consider Tofacitinib 5-10mg bd
2. Low to mid dose Prednisolone 20-30mg tapering
3. Other Rx: Tacrolimus, IVIG
4. Poor prognostic factors: lymphopenia, raised ferritin, old age, rapid ILD progression
Wang GC, IIM session @RheumNow #ACR22 https://t.co/UF2PjAg0Mw
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 8 months ago
Therapies for AS and nr-AxSpA are coming together. Both AS and nr-AxSpA present with similar burden of disease. TNFi, IL-17i and JAKi now approved for use in nr-AxSpA.
Jose U Scher, SpA Review @RheumNow #ACR22 https://t.co/vcHcd7OyAU
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 8 months ago
Mimics of Sjogren’s Syndrome @RheumNow #ACR22 https://t.co/nEAXKb6qF0
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 8 months ago
“The Stone Age did not end because of a shortage of stones. We need new solutions to our problems” Abraham Verghese. Amazing insight into our challenges in clinic today at the #ACR22 opening session @RheumNow
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 8 months ago
GCA Fast Track clinics are nice - but usually need specialized ultrasound.
What if you don't have it? (also, COVID?)
@PennRheum implemented *without* ultrasound
Excellent outcomes
The early referral triage makes all the difference. Knowledge is power ABST0463 #ACR22 @RheumNow https://t.co/rjkVERW559
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
More details at https://t.co/4U8v7oeUYW
Enormously powerful in these times of rheumatology workforce shortage. I would love to see this in Australia and elsewhere - so much to learn. Congratulations to all involved, and thanks @ACRheum and @UCSF for supporting #ACR22
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
